Price movement over the last 24 hours
Avantis vs Bio Protocol — how do they compare? Avantis trades at Rp1,713 (market cap Rp563,68M, Rp462,4M 24h volume), while Bio Protocol trades at Rp504.42 (market cap Rp1,13T, Rp314,5M 24h volume). The key difference: Bio Protocol is far larger — about 2004.7× Avantis's market cap, and Avantis's circulating supply is 329,1M / 1B AVNT (33%) versus 2,2B / 3,3B BIO (68%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Avantis for 19 Days and Bio Protocol for 16 Days on average.
| AVNT | BIO | |
|---|---|---|
Market Cap | Rp563,68M | Rp1,13T |
Volume (24h) | Rp462,4M | Rp314,5M |
Circulating Supply | 329,1M / 1B AVNT (33%) | 2,2B / 3,3B BIO (68%) |
Typical Hold Time | 19 Days | 16 Days |
Signals from Pluang's Aura AI — not financial advice
Avantis (AVNT) is currently trading at Rp1,666, showing bearish technical signals with all moving averages indicating sell. The token has a market cap of Rp542.78 million and a circulating supply of 329.1 million out of 1 million max supply, indicating a high circulation rate of 33%. Recent on-chain activity shows an average hold time of 19 days, suggesting moderate trader turnover. Support levels are found at Rp1,490 (S3) and Rp1,575 (S2), while resistance lies at Rp1,752 (R1) and Rp1,837 (R2).
Overall outlook remains cautious due to strong bearish technical indicators and limited fundamental developments. Key opportunities include potential rebounds from support zones, but risks involve low liquidity and high volatility. Investors should monitor exchange volume and network updates for signs of renewed interest.
Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.
Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.
What Pluang investors did over the last 30 days
Avantis is the largest RWA perpetuals DEX in DeFi, built on Base. It enables users to trade crypto and real-world assets such as FX, commodities, indices, and equities. Supported by Pantera and Coinbase, Avantis combines institutional-grade products with the transparency and accessibility of DeFi, offering leverage up to 500x.
Read more on AVNT →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →